Investing carries serious risks, including partial or total loss of capital. Please read the Information Note and the Risk factors and login before investing.
OLYS Pharma® 1A
Philippe Van Wesepoel
Co-founder
Jean François Plucker
Co-founder
TAX SHELTER 45%
The available budget for Tax Shelter investments has been fully utilised. Investments will not be eligible for the tax shelter advantage.
Raise summary
| Crowd investments | 229,000 € |
| Committed by others | 25,000 € |
| Amount raised | 254,000 € |
| Minimum round | 75,000 € |
| Maximum round | 500,000 € |
| Equity offered | 23.073% |
| Pre-money valuation | 1,667,000 € |
| Post-money valuation min. | 1,742,000 € |
| Post-money valuation max. | 2,167,000 € |